Blue Cross Blue Shield does not cover Cancerguard. Every BCBS plan that has published a policy on multi-cancer early detection tests classifies them as investigational and excludes them from coverage, and Exact Sciences, the test’s maker, does not bill insurance for it. If you want the test, you pay the full self-pay price of $689 out of pocket, though you can use HSA or FSA funds.1CancerGuard. Cancerguard FAQ2CancerGuard. Request the Cancerguard Test
Why BCBS Denies Coverage
BCBS plans treat Cancerguard the way they treat every multi-cancer early detection (MCED) test on the market: as investigational. The reasoning is consistent across licensees. The test is not FDA-approved. No major medical guideline recommends it. And the published studies have not yet shown that using it improves survival or quality of life.
Blue Cross Blue Shield of Massachusetts lists MCED tests as “not a covered service” across its commercial HMO, POS, PPO, indemnity, and Medicare Advantage plans, stating that “no evidence exists” that these tests improve compliance or effectively screen for cancers lacking established screening methods.3Blue Cross Blue Shield of Massachusetts. Multicancer Early Detection Testing – Medical Policy 124 Capital Blue Cross reached the same conclusion in a policy effective November 2025, citing “insufficient evidence to support a general conclusion concerning the health outcomes or benefits.”4Capital Blue Cross. Medical Policy MP 2.387 – Multicancer Early Detection Testing Blue Shield of California says the same in its Policy 2.04.158, noting that estimates of changes in cancer mortality, quality of life, and overdiagnosis rates remain unknown.5Blue Shield of California. Multicancer Early Detection Testing Many of these policies name Galleri because it has been on the market longer, but the reasoning covers Cancerguard and the whole category.
BCBS is not alone. Cigna, through its clinical review partner EviCore, classifies MCED screening tests as “Experimental, Investigational, or Unproven” and does not cover them.6EviCore. Multi-Cancer Early Detection Screening Clinical Guidelines Exact Sciences itself tells patients on its ordering page that Cancerguard “is not currently covered by health insurance.”2CancerGuard. Request the Cancerguard Test
Two legal routes that sometimes force insurer coverage do not apply here. Under the Affordable Care Act, private insurers must cover preventive services that get an “A” or “B” recommendation from the U.S. Preventive Services Task Force at no cost to the patient.7KFF. Preventive Services Covered by Private Health Plans MCED tests have received no USPSTF recommendation.8U.S. Preventive Services Task Force. USPSTF A and B Recommendations Some state biomarker laws also bar plans from denying FDA-approved services as investigational, but as Blue Shield of California’s policy points out, no MCED test has been FDA-approved, so those protections do not apply either.5Blue Shield of California. Multicancer Early Detection Testing
The underlying evidence gap matters because Exact Sciences itself notes that Cancerguard’s reported sensitivity figures come from case-control studies and “may not accurately reflect the test performance in a clinical setting,” adding that “real-world sensitivity may be lower.”9Exact Sciences. Cancerguard MCED Provider Resources That is the gap BCBS cites in its denials.
What You Will Actually Pay
The self-pay price is $689. That price includes an optional telehealth consultation and managed phlebotomy at no extra charge.1CancerGuard. Cancerguard FAQ The test is HSA and FSA eligible, though you should confirm with your account administrator before using those funds.2CancerGuard. Request the Cancerguard Test
Think about the downstream cost too. A positive Cancerguard result is not a diagnosis. It triggers follow-up imaging, often a CT or PET-CT, which can run into the thousands. Because the triggering test is not covered, your BCBS plan may not cover the imaging either.10St. Jude Children’s Research Hospital. Multi-Cancer Early Detection
Exact Sciences runs an Imaging Reimbursement Program to blunt that risk. It covers up to $6,000 in non-covered imaging costs for eligible patients who test positive. It does not reimburse amounts your plan already covered, including copays, coinsurance, or deductibles. You have to apply separately, and eligibility is not guaranteed.9Exact Sciences. Cancerguard MCED Provider Resources Questions go to Exact Sciences at 1-844-870-8870.11CancerGuard. Cancerguard Test Results
Will BCBS Ever Cover Cancerguard?
Not under current rules, and not under the law that just passed. On February 3, 2026, President Trump signed the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act into law as part of a broader spending package.12Prevent Cancer Foundation. Prevent Cancer Foundation Celebrates Landmark Passage of MCED Screening Coverage Act The House passed it on January 22, 2026, by a bipartisan vote of 341 to 88.13Office of Congressman Jodey Arrington. Arrington Celebrates Passage of MCED Screening Coverage Act The law creates a pathway for Medicare to cover MCED tests once they receive FDA approval. It does not force Medicare to cover any test that exists today, and it does not touch private insurers like BCBS.14Office of Congresswoman Terri Sewell. Rep Sewell Celebrates House Passage of the Nancy Gardner Sewell Medicare MCED Screening Coverage Act
FDA approval is the trigger that would open both the Medicare pathway and the state biomarker laws. Cancerguard currently operates as a laboratory-developed test validated under CLIA and CAP standards.15Exact Sciences. Cancerguard MCED for Providers Exact Sciences has said the test “remains under continued clinical evaluation” but has not publicly announced that it has submitted a premarket approval application to the FDA.16Exact Sciences. Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway Private insurer coverage, including BCBS, would likely wait on FDA approval and a USPSTF review after that. The timeline is open-ended.
Don’t Confuse Cancerguard With Cologuard or Shield
The name trips people up. If you came here because your doctor mentioned a cancer screening test and you want to know whether BCBS covers it, make sure you have the right product in mind. These are different tests with different coverage situations.
- Cancerguard, from Exact Sciences, is a blood-based multi-cancer early detection test screening for more than 50 cancer types and subtypes. It is not FDA-approved, not covered by insurance, and costs $689. It does not screen for breast or prostate cancer and is intended for adults 50 to 84 who have not been diagnosed with cancer in the previous three years. It supplements, not replaces, routine screening like mammograms and colonoscopies.1CancerGuard. Cancerguard FAQ17Healthcare Executive. Transforming Early Cancer Detection With the Cancerguard Test
- Cologuard, also from Exact Sciences, is a different product entirely: an at-home stool DNA test for colorectal cancer. It is FDA-approved and covered by Medicare and most private insurers at no cost to eligible average-risk patients 45 and older, once every three years.18American Cancer Society. Colorectal Cancer Screening Coverage Laws
- Guardant Shield is a blood-based colorectal cancer screening test from Guardant Health, FDA-approved in July 2024 for average-risk adults 45 and older. Even with FDA approval, Blue Cross and Blue Shield of Texas lists it as not reimbursable, and Blue Shield of California classifies blood-based colorectal cancer screening as investigational.19Memorial Sloan Kettering Cancer Center. Is Shield a Good Colorectal Cancer Screening Blood Test20Blue Cross and Blue Shield of Texas. Clinical Payment and Coding Policy CPCPLAB07121Blue Shield of California. Oncology Cancer Screening
- Galleri, from GRAIL, is the other major MCED blood test. Like Cancerguard, it is a laboratory-developed test without FDA approval, and BCBS and other major insurers classify it as investigational and do not cover it.4Capital Blue Cross. Medical Policy MP 2.387 – Multicancer Early Detection Testing
If your interest is colorectal cancer screening specifically, Cologuard is covered and Cancerguard is not the test you want. If your interest is screening for the aggressive cancers that lack routine screening methods, Cancerguard is what Exact Sciences offers, but you will be paying for it yourself.